Valeant Settles for Second Best with US$14.5 B Salix Acquisition

By Heather Cartwright

Pharma Deals Review: Vol 2015 Issue 3 (Table of Contents)

Published: 12 Mar-2015

DOI: 10.3833/pdr.v2015.i3.2097     ISSN: 1756-7874

Section: Mergers & Acquisitions



In its biggest deal to date, Valeant Pharmaceuticals International has agreed to buy gastrointestinal specialist Salix Pharmaceuticals for an enterprise value of approximately US$14...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details